Latest news with #Biosenta
Yahoo
21-07-2025
- Business
- Yahoo
Veteran Finance Executive Tim Gillespie, CFA, Joins Biosenta as Strategic Advisor
Former ATB Financial executive vice-president brings more than 35 years of capital-markets and corporate-banking experience to accelerate Biosenta's growth Toronto, Ontario and Calgary, Alberta--(Newsfile Corp. - July 21, 2025) - Biosenta Inc. (CSE: ZRO) ("Biosenta") today announced that Tim Gillespie, CFA has joined the company as a strategic advisor. In this role, Mr. Gillespie will counsel Biosenta's executive team and board on financing, risk management and go-to-market strategy as the company scales production and commercialization of its Tri-Filler™ antimicrobial technology. Tim Gillespie, CFA, joins Biosenta Inc. as strategic advisor. (CNW Group/Biosenta Inc.) To view an enhanced version of this graphic, please visit: Mr. Gillespie served as Executive Vice-President and Head of Corporate Financial Services at ATB Financial, where he led 200 specialists, managed a $20-billion loan portfolio and supported clients across the energy, real estate, technology and transportation sectors. His career spans more than three decades in corporate lending and capital markets, beginning as an international equities trader in Denmark. He currently sits on the boards of several Canadian organizations in both the for-profit and non-profit sectors. "Tim's track record of structuring complex financings and guiding high-growth companies is exactly what we need as we move Tri-Filler from pilot plant to full commercial production," said Am Gill, President and CEO of Biosenta. "His insight into capital markets and strategic partnerships will help us deliver antimicrobial solutions to customers faster." "Biosenta's technology has the potential to redefine how industries protect people from deadly pathogens," said Tim Gillespie. "I look forward to working with the team to secure the resources and relationships needed to bring Tri-Filler to market at scale." About Biosenta Inc. Biosenta Inc. develops innovative antimicrobial products that offer environmentally friendly solutions to a global market. Based in Toronto, Ontario and Calgary, Alberta, the company is dedicated to the advancement of technology that combats microbial growth in various materials. Biosenta's flagship product, Tri-Filler®, represents a breakthrough in antimicrobial technology, providing durable protection against a wide spectrum of bacteria, molds, and fungi. For further inquiries, please contact: Am Gill, President and CEO, Biosenta Inc. Email: info@ Phone: 416-410-2019 For more information, visit our website: Forward-Looking Statements This press release contains forward-looking information within the meaning of applicable securities laws ("forward-looking statements"), including forward-looking statements relating the completion of the Transaction. Such forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements to differ materially from the anticipated results, performance or achievements or developments expressed or implied by such forward-looking statements. If any such risks actually occur, they could impact the potential for discussion, agreement or completion of the Transaction and/or materially adversely affect the Company's business, financial condition or results of operations. In that case, the trading price of the Company's common shares could decline, perhaps materially. Readers are cautioned not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Forward-looking statements are provided for the purposes of providing information about management's current expectations and plans relating to the future. Readers are cautioned that such information may not be appropriate for other purposes. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in the Company's expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law. Disclaimer The CSE has in no way passed upon the contents of this news release and further, has neither approved nor disapproved of the contents of this news release. Neither the CSE nor its Regulation Services Provider (as such term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
The Market Online
26-06-2025
- Health
- The Market Online
Why These 3 Canadian Brands Deserve a Spot on Your Shopping List
Innovation, wellness, and sustainability—made right here at home. In today's fast-moving world, we're always on the lookout for the next big thing—whether it's a breakthrough in health, a smarter way to stay fit, or a more sustainable solution for our homes. But often, the most exciting innovations aren't coming from across the globe—they're being developed right here in Canada. This Canada Day, we're shining a spotlight on three standout Canadian companies and brands that are pushing boundaries and proving that world-class innovation doesn't have to come from far away. Aja Health and Wellness (TSXV:AJA) , Promino Nutritional Sciences (CSE:MUSL) , and Biosenta Inc.(CSE:ZRO) are three brands that deserve a spot on your shopping list. Aja Health and Wellness: Nature Meets Next-Gen Health Aja Health and Wellness is transforming how we approach everyday health challenges. With its subsidiaries—Aja Therapeutics, MyCare, and GOeVisit—the company blends traditional wellness principles with advanced technology to offer convenient, natural, and effective health solutions. One of their latest innovations is a nasal spray designed to provide relief for migraine sufferers. Unlike conventional medications, Aja's formula is based on BioFlora, a proprietary blend of over 20 plant-derived flavonoids. One of those flavonoids, apigenin, has shown to be up to 30 times more effective than aspirin in reducing inflammation. Aja Health and Wellness is up 50 per cent year-to-date and their products available online. Promino Nutritional Sciences: Muscle Health, Reinvented Next up is Promino Nutritional Sciences, a Canadian company rewriting the rules of muscle health. If you're into fitness, recovery, or just staying active, Promino's Rejuvenate Muscle unlike traditional protein powders, delivers the equivalent muscle-building impact of 40 grams of whey protein, but without the added calories, sugars, or fillers. And here's the kicker: the formula was developed with input from NASA. It's space-grade science, tailored for everyday performance—and it's made in Canada. Finally, we have Biosenta, a Canadian company on a mission to make our world cleaner—and safer . With antimicrobial resistance on the rise, Biosenta's Tri-Filler technology is a breakthrough that provides long-lasting protection against bacteria and mold, without relying on harsh chemicals. The company's TRUE disinfectant sprays and wipes are eco-friendly, tough on germs, and affordable—starting at just C$4.99. From homes to hospitals to construction materials, Biosenta is working behind the scenes to make spaces cleaner and healthier, without compromising the planet. Why It Matters These companies aren't just Canadian—they're creating meaningful solutions to real problems. They're making it easier to manage pain, build strength, and protect our homes in ways that are smarter, cleaner, and more sustainable. And as we celebrate Canada, what better time to support the kind of innovation that starts right here at home? So whether you're restocking your wellness shelf, looking to boost your fitness game, or simply want cleaner, greener products— these Canadian brands, may deserve a spot on your shopping list. names. Join the discussion: Check out Stockhouse's stock forums and message boards. The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
Yahoo
11-06-2025
- Health
- Yahoo
Biosenta's Tri-Filler(TM) Nanoparticles Achieve 100% Killing of Pathogens at Industry-Low Dose in Peer-Reviewed Studies
Validated University of Calgary research demonstrates broad-spectrum efficacy of core-shell calcium hydroxide-calcium carbonate (CSCC(TM)) particles Toronto, Ontario and Calgary, Alberta--(Newsfile Corp. - June 11, 2025) - Biosenta Inc. (CSE: ZRO) ("Biosenta") today announced that two independent, peer-reviewed studies conducted at the University of Calgary confirmed that its proprietary Tri-Filler™ core-shell calcium hydroxide-calcium carbonate (CSCC™) nanoparticles achieved complete (100 %) bactericidal activity against multiple World Health Organization (WHO) priority pathogens and keep working far longer than conventional biocides. "Transforming a readily available mineral into a durable, broad-spectrum antimicrobial opens new opportunities for safer surfaces in hospitals, transit systems and homes," said Dr. Mehdi Mohammadi Ashani, lead author of both papers. Key laboratory findings The research, conducted and independently validated by University of Calgary scientists, is detailed in two recent peer-reviewed publications in Colloids and Surfaces A and The Canadian Journal of Chemical Engineering.¹ ² These studies confirmed Tri-Filler's™ potent efficacy against multiple World Health Organization priority bacterial pathogens, including: Gram-negative bacteria: Escherichia coli (E. coli), Pseudomonas aeruginosa Gram-positive bacteria: Staphylococcus aureus (including MRSA) These findings were validated using both Minimum Inhibitory Concentration (MIC) and Minimum Biocidal Concentration (MBC) protocols, with consistent 100% elimination rates at the 2.5 mg/mL threshold across these bacterial strains. Traditional biocides rely on frequent re-application and can trigger resistance or toxicity. The 100 % kill rates reported above were obtained under controlled laboratory conditions. In addition, Biosenta has obtained similar promising results against other significant microbes, including the Gram-positive bacterium Enterococcus faecalis and fungi Candida auris and Candida albicans. These results are currently under preparation for peer-reviewed publication. "Achieving 100 per cent eradication across three WHO-priority species by a more environmentally friendly biocide at such relatively low dose moves Tri-Filler™ into a class of its own and is a decisive step toward safer, longer-lasting antimicrobial surfaces," added Dr. Maen Husein, professor of chemical and petroleum engineering and senior author of the papers. From personal loss to public good Biosenta's president and CEO Am Gill lost his uncle to a hospital-acquired infection. That tragedy drives the company's mission and underpins a $140-thousand donation to the Alberta Centre for Advanced Diagnostics to accelerate nanoparticle research. "We're turning grief into action," Gill said. "Embedding Tri-Filler™ into concrete, paint and coatings will let us stop pathogens at the surface and save lives."What happens next Regulatory filings - Health Canada and U.S. EPA submissions for Tri-Filler™-enabled products are in preparation. Manufacturing scale-up - Bench output already tops 170 kg day; full commercial plant design is under way. About Biosenta Inc. Biosenta Inc. develops innovative antimicrobial products that offer environmentally friendly solutions to a global market. Based in Toronto, Ontario and Calgary, Alberta, the company is dedicated to the advancement of technology that combats microbial growth in various materials. Biosenta's flagship product, Tri-Filler®, represents a breakthrough in antimicrobial technology, providing durable protection against a wide spectrum of bacteria, molds, and fungi. For further inquiries, please contact: Am Gill, President and CEO, Biosenta info@ 416-410-2019 For more information, visit our website: References N. Darwish, M. M. Ashani, A. Mehairi, I. A. Lewis, M. M. Husein, "Synthesis of uniform core-shell calcium hydroxide-calcium carbonate biocidal particles via encapsulation into dry ice," Canadian Journal of Chemical Engineering, 2025, 1. DOI: 10.1002/cjce.25670. N. Darwish, M. M. Ashani, I. A. Lewis, M. M. Husein, "Controlled carbonation of Ca(OH)₂ surface and its application as an antibacterial particle," Colloids and Surfaces A: Physicochemical and Engineering Aspects, 2024, 682. DOI: 10.1016/ Forward-Looking Statements This press release contains forward-looking information within the meaning of applicable securities laws ("forward-looking statements"), including forward-looking statements relating the completion of the Transaction. Such forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements to differ materially from the anticipated results, performance or achievements or developments expressed or implied by such forward-looking statements. If any such risks actually occur, they could impact the potential for discussion, agreement or completion of the Transaction and/or materially adversely affect the Company's business, financial condition or results of operations. In that case, the trading price of the Company's common shares could decline, perhaps materially. Readers are cautioned not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Forward-looking statements are provided for the purposes of providing information about management's current expectations and plans relating to the future. Readers are cautioned that such information may not be appropriate for other purposes. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in the Company's expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law. Disclaimer The CSE has in no way passed upon the contents of this news release and further, has neither approved nor disapproved of the contents of this news release. Neither the CSE nor its Regulation Services Provider (as such term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. To view the source version of this press release, please visit
